Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients
Kai Shen,Minjie Yang,Yaxin Fan,Xiaoyu Liang,Yuancheng Chen,Jufang Wu,Jicheng Yu,Huifang Zhang,Ruilan Wang,Fengying Zhang,Jingqing Hang,Xiaoxing Wen,Huayin Li,Lihua Shen,Zhongwei Zhang,Shengbin Wu,Bo Shen,Weifeng Huang,Chunkang Chang,Yuqi Shen,Hong Ren,Qing Yuan,Xiaolian Song,Xuming Duo,Hong Zhang,Wanqiu Yang,Jiansong Yang,Jing Zhang
DOI: https://doi.org/10.1093/cid/ciy667
IF: 20.999
2018-01-01
Clinical Infectious Diseases
Abstract:Background. Our aims in this prospective study were to evaluate the correlations between pharmacokinetic/pharmacodynamic (PK/PD) indices and the clinical/microbiological efficacy of vancomycin and to identify an appropriate PK/PD target in the Chinese population to guide vancomycin treatment in the clinic. Methods. Adult patients from 11 hospitals in China with gram-positive infections who received vancomycin therapy for >= 5 days and who were under therapeutic drug monitoring (TDM) were enrolled in this study. A 1-compartment population PK model was established and validated. The correlations between PK/PD indices (C-min, C-max, 0-24 hour area under the curve (AUC(0-24)), and AUC(0-24)/minimum inhibitory concentration (MIC) and clinical outcomes (clinical efficacy and bacterial eradication) were evaluated. Results. In total, 402 adult Chinese patients were enrolled. Among them, 380 patients were evaluable for PK analysis, and 334 were evaluable for PK/PD analysis. In the final population PK model, creatinine clearance (CLCR) was the significant covariate on CL (typical value, 3.87 L/hour; between-subject variability (BSV), 12.5%), and age was the significant covariate on volume of distribution (V) (typical value, 45.1 L; BSV, 24.8%). The univariate analysis showed that C-max, AUC(0-24), and AUC(0-24)/MIC were significantly different or marginally significantly different (P values were 0.009, 0.0385, and 0.0509, respectively) between microbiological outcome groups with coagulase-negative Staphylococcus infections. However, there were no significant differences (P > .05) in the above PK parameters by multivariate logistic regression analysis, indicating there was no independently associated factor. Conclusions. No significant correlations were identified between PK/PD indices and the clinical or microbiological efficacy of vancomycin in Chinese patients. The necessity of vancomycin TDM based on trough concentration and the current treatment target of AUC(0-24)/MIC >= 400 need to be further evaluated and confirmed in additional prospective studies.